XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cash, Cash Equivalents, and Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents and Marketable Investment Securities

The following table shows the Company’s cash, cash equivalents, and marketable investment securities by significant investment category:

 

   December 31, 2023 
   Adjusted Cost   Allowance for Credit Losses   Total Unrealized Gains / (Losses)   Fair Value   Cash and Cash Equivalents   Marketable Investment Securities 
Cash  $4,317,449   $-   $-   $4,317,449   $4,317,449   $- 
Level 1:                              
Money market funds   10,599,429    -    -    10,599,429    10,599,429    - 
Subtotal   10,599,429    -    -    10,599,429    10,599,429    - 
Level 2:                              
U.S. treasury securities   43,484,810    -    146,700    43,631,510    -    43,631,510 
Subtotal   43,484,810    -    146,700    43,631,510    -    43,631,510 
Total  $58,401,688   $       -   $146,700   $58,548,388   $14,916,878   $43,631,510 

 

   December 31, 2022 
   Adjusted Cost   Allowance for Credit Losses   Total Unrealized Gains / (Losses)   Fair Value   Cash and Cash Equivalents   Marketable Securities 
Cash  $12,834,444   $-   $-   $12,834,444   $12,834,444   $- 
Level 1:                              
Money market funds   146,359           -    -    146,359    146,359    - 
Subtotal   146,359    -    -    146,359    146,359    - 
Level 2:                              
U.S. treasury securities   67,892,825    -    389,241    68,282,066    9,993,000    58,289,066 
Subtotal   67,892,825    -    389,241    68,282,066    9,993,000    58,289,066 
Total  $80,873,628   $-   $389,241   $81,262,869   $22,973,803   $58,289,066